Abstract
Tigliane and daphnane diterpenoids are characteristically distributed in plants of the Thymelaeaceae family as well as the Euphorbiaceae family and are structurally diverse due to the presence of polyoxygenated functionalities in the polycyclic skeleton. These diterpenoids are known as toxic components, while they have been shown to exhibit a wide variety of biological activities, such as anti-cancer, anti-HIV, and analgesic activity, and are attracting attention in the field of natural product drug discovery. This review focuses on naturally occurring tigliane and daphnane diterpenoids from plants of the Thymelaeaceae family and provides an overview of their chemical structure, distribution, isolation, structure determination, chemical synthesis, and biological activities, with a prime focus on the recent findings.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Thymelaeaceae family is distributed throughout the world except in the arctic zones, with 53 genera and more than 800 species [1, 2]. Most of them are trees or shrubs, rarely perennial or annual. The plants of this family are not only popular as ornamental trees but also have a wide range of uses including incense, paper-making material, and traditional medicine. For example, agarwood, a non-timber resinous wood obtained mainly from the genera Aquilaria and Gyrinops, has a long history as a high-grade incense and has played an important role in the traditional medicine of Asian Nation [3]. Bast fibers collected from Edgeworthia chrysantha and Wikstroemia sikokiana have long been used to make high-quality paper and banknotes in Japan [4]. Some of them, such as Daphne genkwa and Stellera chamaejasme, have a long history as medicinal plants used in traditional Chinese medicine [5].
Tigliane and daphnane diterpenoids, which are characteristically distributed in plants of the Thymelaeaceae family as well as the Euphorbiaceae family, are structurally diverse due to the presence of polyoxygenated functionalities in the polycyclic skeleton. These diterpenoids, such as phorbol esters of tigliane and daphnetoxin of daphnane, are known as toxic components, while they have been shown to exhibit a wide variety of biological activities and are attracting attention in the field of natural product drug discovery.
12-O-Tetradecanoylphorbol 13-acetate (TPA; phorbol 12-myristate 13-acetate, PMA, 1), a tigliane diterpenoid also known as phorbol ester, is a potent tumor promoter that exerts its effects through the activation of protein kinase C (PKC) (Fig. 1) [6]. It has been utilized as a reagent in pharmacological studies to activate downstream signaling pathways as a PKC agonist. Resiniferatoxin (2), a daphnane diterpenoid, is an analog of capsaicin that shows potent analgesic effects by stimulating transient receptor potential vanilloid 1 (TRPV1) [7,8,9]. It is expected to be developed as a non-addictive analgesic with reduced side effects in comparison with morphine, since it does not act on opioid receptors. Currently, phase II and III clinical trials are underway to evaluate the efficacy of 2 for the management of cancer pain and knee osteoarthritis-related pain [10].
Attractive tigliane and daphnane diterpenoids have previously been described in reviews by Liao et al. in 2009 and Wang et al. in 2015 [11, 12]. However, since the publication of these reviews, further advancements have been made in the research of naturally occurring tigliane and daphnane diterpenoids. Therefore, this review focuses on naturally occurring tigliane and daphnane diterpenoids from plants of the Thymelaeaceae family and provides an overview of their chemical structure, distribution, isolation, structure determination, chemical synthesis, and biological activities, with a prime focus on the recent findings.
Chemical structure
Tigliane and daphnane diterpenoids are considered to be biosynthesized from casbene. While the exact mechanisms have not been fully elucidated, it is thought that the reaction catalyzed by casbene synthase from geranylgeranyl diphosphate (GGPP) generates casbene, which undergoes ring-closing reactions to form lathyrane, leading to tigliane. Then, the cyclopropane ring of tigliane opens to form an isopropyl group to form daphnane (Fig. 2). These skeletons are further modified by various oxygenation and esterification reactions, giving rise to tigliane and daphnane diterpenoids with a diverse array of chemical structures [13, 14].
Tigliane diterpenoids possess a 5/7/6/3 (A/B/C/D) fused tetracyclic structure, wherein the D-ring forms a gem-dimethylcyclopropane ring. In all of tigliane isolated from plants of the Thymelaeaceae family, the A/B and B/C rings are trans-fused, while the C/D ring is cis-fused. Tigliane with an α,β-unsaturated ketone structure in the A-ring, a double bond between C-6 and C-7, a primary hydroxy group at C-20, a secondary hydroxy group at C-12, and tertiary hydroxy groups at C-4, C-9, and C-13 are known as phorbol (3). The group of compounds in which the hydroxy group at C-12, C-13, or C-20 of phorbol is esterified is typically referred to as phorbol esters, representing the most canonical class of tiglianes (Fig. 3). In addition, there is 12-deoxytigliane, which lacks a substituent attached to C-12. Although most of the known tiglianes have been isolated from plants of the Euphorbiaceae family, those isolated from the Thymelaeaceae family are with diverse patterns of oxidative modification of the B-ring, showing the variety of skeletal parts (Fig. 4).
On the other hand, the majority of daphnane diterpenoids are isolated from plants of the Thymelaeaceae family rather than the Euphorbiaceae family. Daphnanes possess a 5/7/6 (A/B/C) trans-fused tricyclic structure, which is characterized by an isopropenyl group attached to the C-ring. Daphnanes isolated from the Thymelaeaceae family can be classified into three types based on their chemical structural characteristics. The first type is the orthoester daphnane type, which is the most commonly found structure among daphnanes, characterized by an orthoester acylate formed at C-9, C-13, and C-14 of the C-ring (Fig. 5). The second type is the polyhydroxy daphnane type, which does not form orthoester acylate but has a polyhydroxy structure, with most compounds esterified at C-14. The third type is the macrocyclic daphnane orthoester (MDO) type (1α-alkyldaphnane), which has only been isolated from plants of the Thymelaeaceae family. In this type, the aliphatic chain with an orthoester linkage to C-9, C-13, and C-14 is connected to C-1 of the A-ring, forming a macrocyclic ring that spans the skeleton (Fig. 6). The oxidative modification patterns of orthoester daphnanes and polyhydroxy daphnanes types are similar, and both types typically have an α,β-unsaturated ketone in the A-ring, as well as a 6,7-epoxy group in the B-ring. Similar to tiglianes, there are daphnanes with either hydroxy or acyloxy groups attached to the C-12 of the C-ring as well as daphnanes with no substituents attached. Additionally, daphnanes with a 1,2-dihydro, 3-hydroxy (or 3-acyloxy), 1,2-dihydro-3-hydroxy (or 3-acyloxy) structure for the A-ring and 6,7-hydroxy structure for the B-ring have been identified. The polyhydroxy daphnanes are also characterized by the presence of compounds with 4,6-epoxy and 4,7-epoxy structures. The MDOs are divided into three categories based on the length of aliphatic chains spanning the diterpene skeleton: C10 aliphatic chain, C14 aliphatic chain, and C16 aliphatic chain. Among them, the C10 aliphatic chain type is the most popular and shows the greatest chemical structural diversity. The C10 and C14 aliphatic chain types can be further classified into compounds with a five-membered ring structure or a bicyclo ring structure for the A-ring, while only compounds with a cyclopropanone structure for the A-ring have been reported for the C16 aliphatic chain type.
Distribution
Phytochemical investigations on plants of the Thymelaeaceae family have reported the isolation of diterpenoids from 17 genera (Table 1), most from Daphne, Stellera, Wikstroemia, and Pimelea. Among them, the plants being most extensively studied and most abundant source of diterpenoids are Daphne genkwa and Stellera chamaejasme, which have also been used in traditional Chinese medicines. Orthoester daphnanes are the most commonly distributed diterpenoids in plants of the Thymelaeaceae family. However, only tiglianes have been reported from Aquilaria, and only MDOs from Dirca and Edgeworthia. Among MDOs, the distribution of C14 and C16 aliphatic chain types is very limited, with the C14 aliphatic chain type being reported from Edgeworthia and the C16 aliphatic chain type being reported from Synaptolepis [15,16,17,18].
Isolation
The isolation of tigliane and daphnane diterpenoids from plants involves several steps. Firstly, the dried plant is extracted using an organic solvent, such as ethanol or methanol, followed by liquid–liquid partitioning. Since tigliane and daphnane diterpenoids have low polarity, they are partitioned into low-polarity solvents, including ethyl acetate, chloroform, petroleum ether, hexane, or dichloromethane [13, 19, 20]. Then, silica gel and ODS silica gel column chromatography are frequently employed to fractionate the extracts. Finally, isolation and purification are typically achieved by reversed-phase preparative HPLC, which uses acetonitrile/water or methanol/water mobile phases. During the process of isolating and purifying tigliane and daphnane diterpenoids, they are often contaminated by commonly occurring chemical constituents such as fatty acids, acylglycerols, and chlorophyll. In particular, when the chemical behavior of diterpenoids, fatty acids, and acylglycerols are similar, it is difficult to remove these impurities to isolate trace amounts of diterpenoids [21]. Based on our experience, the following methods can be employed as possible solutions during the isolation and purification process: (1) Ion exchange resin or basic resin-based column chromatography is useful to eliminate acidic fatty acids. (2) When partial separation can be achieved in HPLC, recycling HPLC is effective for purification. (3) Compounds that cannot be separated at all by reversed-phase HPLC are likely to be structural isomers. In such cases, purification by normal-phase HPLC using mobile phases such as n-hexane/ethyl acetate or chloroform/methanol mixtures should be considered [22].
Regarding the stability of these diterpenoids during isolation, purification, and storage, it is desirable to store them in the dark under low-temperature conditions practically when kept in a solution. This is because autoxidation of the B-ring has been observed to occur in the solution state over a long period at room temperature for tiglianes (Fig. 7) [23]. On the other hand, in daphnanes, especially in compounds with a 3,5,20-trihydroxy structure, acyl transfer is likely to occur between these hydroxy groups. In polyhydroxy daphnanes, acyl transfer also occurs between the C-13 and C-14 hydroxy groups [24].
Structure determination
The chemical structures of tigliane and daphnane diterpenoids have been primarily determined through NMR spectral analysis. Generally, these diterpenoids exhibit poor crystallinity, and there are limited reports of X-ray crystallographic analyses [25,26,27,28]. The 1H and 13C-NMR spectra of tigliane and daphnane diterpenoids share similarities but can be readily differentiated by observing the characteristic signals derived from the gem-dimethylcyclopropane group in tiglianes or the isopropenyl group in daphnanes, respectively.
Tigliane diterpenoids
In the 1H and 13C-NMR spectra of tiglianes, the characteristic resonances of the gem-dimethylcyclopropane moiety are observed as two singlet methyl proton resonances and an upfield shifted quaternary carbon resonance at ca. δC 22–28 [12]. All of the tiglianes isolated from plants of the Thymelaeaceae family possess an α,β-unsaturated ketone group in the A ring. Therefore, a downfield shifted resonance of olefinic proton and carbon resonances of the ketone group are observed. Moreover, methyl proton resonance of H3-19 is always observed as a broad singlet, broad doublet, or double doublet, since H3-19 is in long-range coupling with H-1 and H-10, when a double bond is located between C-1 and C-2. Generally, C-12 and C-13 have hydroxy or acyloxy groups attached to them, and the acyloxy group attached to C-12 can be easily determined by observing the HMBC correlation from H-12 to the esterified carbonyl carbon resonance. Since C-13 is an oxygenated tertiary carbon, it is difficult to determine the attachment of an acyloxy group by observation of the HMBC correlations. However, 13-hydroxytiglianes and 13-O-acylated tiglianes can be distinguished by observation of the chemical shift of C-13 of 13-hydroxytiglianes (4) at ca. δC 61, and of 13-O-acylated tiglianes (5 and 6) at ca. δC 63–67 (Fig. 8) [29]. The configurational analysis of tiglianes is generally performed by interpretation of NOESY (or ROESY) correlations and ECD Cotton effects, sometime combined with molecular modeling by quantum chemical calculations. The most common tiglianes have a trans-A/B/C ring structure, and observation of NOE (or ROE) from the α-oriented H-10 and β-oriented H-8 at the ring junction is useful for analysis of relative configurations. Although all of the tiglianes isolated from plants of the Thymelaeaceae family have a β-oriented 4-OH, a small number of tiglianes isolated from the Euphorbiaceae family have cis-fused A/B ring with α-oriented H-4/4-OH. The orientation of 4-OH can be determined by the chemical shift of C-4, at δC 76.9 for α-oriented 4-OH (6) and ca. δC 72–75 for β-oriented 4-OH (4 and 5) [30, 31].
ECD spectroscopy is commonly a useful tool to determine the absolute configuration of tiglianes. The Cotton effect of tigliane generally occurred in four regions: 320–340 nm (n → π* transition), 240–260 nm (π → π* transition), 220–240 nm (π → π* transition), and 200–220 nm (π → π* transition). The Cotton effect observed at 220–260 nm arising from the π → π* transition of the chromophore present in the A ring is useful in determining the absolute configuration [32]. Generally, in tiglianes with α,β-unsaturated ketone (C=C–C=O chromophore) and 4β-OH in the A ring, the Cotton effects are observed positive at 240–260 nm and negative at 220–240 nm. In addition, the differences in the B ring structure (differences in the position of hydroxy groups, ketone groups, or double bonds) may affect the Cotton effects at 220–260 nm and careful attention should be paid when analyzing the absolute configurations [33].
Daphnane diterpenoids
In the 1H-NMR spectra of daphnanes, the characteristic resonances of the isopropenyl moiety are observed as an upfield shifted olefinic proton resonance of the terminal olefin and a methyl proton resonance in long-range coupling with the terminal olefin protons. Additionally, in orthoester daphnanes (7) and MDOs (11 and 12), a characteristic quaternary carbon resonance of the orthoester moiety is observed at ca. δC 116–120 in the 13C-NMR spectra [11]. Polyhydroxy daphnanes (8–10) are distinguished by the absence of the characteristic orthoester carbon resonances and the oxygenated carbon resonances at C-9, C-13, and C-14 downfield shifted compared to those in orthoester daphnanes (7) (Fig. 9) [28, 34].
The A-ring structure of orthoester daphnanes and polyhydroxy daphnanes resembles those of tiglianes, possessing a cyclopentenone or cyclopentanol structure. Consequently, the resonance of H-1 is observed as either an olefinic proton or a methylene proton resonance. On the other hand, in MDOs, the resonance of H-1 is observed as a methylene proton resonance due to carbon–carbon bond formation with the macrocyclic ring moiety at C-1. In addition to MDOs with a five-membered A-ring structure, some compounds (12) are with a bicyclo[2.2.1]heptane A-ring structure, in which the resonances of an acetal carbon at ca. δC 112–113 and a lactone carbonyl carbon at ca. δC 172–174 are observed in the 13C-NMR spectra (Fig. 10) [18, 19, 35,36,37,38]. In the B-ring, most daphnanes (7, 9, 11, and 12) have an α-oriented 6,7-epoxy group, with the oxymethine carbon resonance of C-7 observed at ca. δC 59–65 ppm [39], and H-7 characteristically observed as a singlet, which may be attributed to a dihedral angle of approximately 90° between H-7 and H-8. The resonances of C-6 and C-7 in compounds with 6,7-dihydro, 4,6-epoxy, and 4,7-epoxy structure are downfield shifted from those with a 6,7-epoxy group. Furthermore, the resonance of C-4 is observed at ca. δC 90–92 for compounds (8) with a 4,7-epoxy structure and at δC 95.3 for the compound (10) with a 4,6-epoxy structure (Fig. 9). In daphnanes with an orthoester moiety, H-11α and H-12α in the C-ring are not coupled to each other since the dihedral angle between them is approximately 90°. Namely, in the case of a hydroxy or acyloxy group attached to C-12, H-12α is observed as a characteristic singlet. In the case of no substituent attached to C-12, H-12α is observed as a doublet due to coupling with H-12β, and H-12β is observed as a double doublet due to coupling with H-12α and H-11.
Daphnanes have only been reported with trans-A/B/C ring structure so far, and their configurations are analyzed in the same way as that of tiglianes, but the ECD spectroscopy is not well applied for the analysis of the absolute configuration due to the lack of chromophore in the structure. While the number of daphnanes with characterized structures using X-ray crystallography is limited, there have been some compounds with diverse structural features that have been studied in this way. For example, polyhydroxy daphnane with a 4,7-epoxy structure (13) and MDO with a bicyclo[2.2.1]heptane A-ring structure (14) have been subjected to X-ray crystallography, providing valuable information about their absolute configuration and conformation (Fig. 11) [28, 35]. Determination of the relative configuration of alkyl groups branching on the macrocyclic ring part is a key point in the structural elucidation of MDOs, requiring careful analysis of NOE (or ROE). Recently, we reported a facile way to assign the relative configuration of the methyl group at C-9′ in the C10 aliphatic chain-type MDO by observing the chemical shift of C-10 or C-10′ [35].
Structure analysis by ESI–MS/MS fragmentation
Recently, ESI–MS/MS fragmentation pathway analysis utilizing tandem mass spectrometry has been reported for tigliane and daphnane diterpenoids isolated from plants of the Thymelaeaceae family. Both tiglianes and daphnanes show abundant product ions in the positive mode, with a series of product ions observed at m/z 200–400 attribute to the consecutive losses of H2O and C=O from the C20 diterpene skeleton subsequent to the dissociation of the acyloxy and orthoester moieties (Fig. 12) [22, 40,41,42]. In tiglianes without a substituent attached to C-12, the characteristic product ion is observed in which the C5H6 unit is eliminated from the C-ring by the retro-Diels–Alder (RDA) reaction [42]. The characteristic product ion observed in daphnanes is the elimination of the C3H4O unit from the B-ring, which results in the fusion of a 7-membered ring to a 6-membered ring [40]. On the other hand, in the MDOs, the orthoester moiety is cleaved similarly to the orthoester daphnanes. However, abundant product ions are observed around m/z 400–500 due to consecutive losses of H2O and C=O while retaining the aliphatic chain in the A-ring [22]. As mentioned above, the ESI–MS/MS fragmentation of tiglianes and daphnanes is highly specific to their chemical structure. Therefore, LC–MS/MS analysis is a useful tool for the rapid identification of tiglianes and daphnanes in plants.
Chemical synthesis
Tigliane and daphnane diterpenoids pose significant synthetic challenges due to their complex structures, but given their biological importance, numerous synthetic approaches have been reported by chemists [43]. The total synthesis of tigliane diterpenoids has been reported by several research groups, starting with the first total synthesis of phorbol (3) in 1989 [44, 45]. In 2008, a practical semi-synthetic method was developed to synthesize prostratin (16) and its derivative 12-deoxyphorbol-13-phenylacetate (DPP, 17), which are drug candidates for the treatment of HIV infection. This method provides the synthesis of 16 and 17 in less than five steps from phorbol (3) or a rhamnofolane diterpenoid, crotophorbolone (15), which are readily available either naturally or synthetically (Fig. 13) [46]. This practical semi-synthetic method has made it possible to supply 16 and 17 on a gram basis, representing a significant step forward in drug development. More recently, tigilanol tiglate (EBC-46, 18) with 5β-hydroxy-6α,7α-epoxy structure, which is a veterinary drug to treat dog cutaneous mast cell tumors, has been reported its synthesis in a high yield (12% overall yield) from phorbol (3) in only 12 steps. This method is also expected to be applied for synthesizing daphnanes with the same B-ring structure, which has not been achieved thus far [47]. In daphnane diterpenoids, since the first total synthesis of resiniferatoxin (2), an analgesic candidate with a 6-ene structure similar to phorbol (3), was reported in 1997, its synthetic route has been optimized and updated until 2022 [48,49,50]. The total synthesis of daphnanes with 6,7-epoxy structure has only been reported for 6,7-epi-yuanhuapin (19), but as mentioned above, the total synthesis of daphnanes with 5β-hydroxy-6α,7α-epoxy structure, which is primarily isolated from the plants of Thymelaeaceae family, has not yet been achieved (Fig. 14) [51]. Furthermore, the macrocyclic ring in MDOs increases the structural complexity, and despite attempts, linking the macrocyclic ring to the daphnane skeleton through chemical synthesis still remains a challenge [52].
Biological activity
Tigliane and daphnane diterpenoids have been found to have a variety of attractive biological activities. Phorbol esters belonging to tiglianes are known to stimulate protein kinase C (PKC) by acting as a substitute for diacylglycerol, a naturally occurring second messenger. Daphnane diterpenoids with similar chemical structures are also considered to have the same function. PKC plays a role in the regulation of protein synthesis, DNA expression, and cell transformation [53]. The effects of tiglianes and daphnanes on PKC are known to include tumor-promoting and inflammatory activities, as described by PMA (1) [54]. However, these diterpenoids are not limited to “negative” biological activities. Some compounds (16–24) exhibit “positive” biological activities such as anti-cancer and anti-HIV without showing PKC-mediated tumor-promoting and inflammatory activities (Fig. 15). This difference in activity is thought to be due to the selectivity of these diterpenoids for the PKC isozymes [55].
Anti-cancer activity
Since the PKC family plays a key role in cell proliferation and vasculature formation that is critical for tumor growth and has been identified as a direct target of “tumor-promoting” phorbol esters, inhibition of the PKC signaling pathway has long been a target of anti-cancer therapy [56]. However, recent studies have shown that PKC isozymes should be activated rather than inhibited in cancer therapy [57]. This finding emphasizes the importance of developing PKC activators for novel anti-cancer drugs [58,59,60]. Most recently, tigilanol tiglate (18), a tigliane diterpenoid, was approved by the US Food and Drug Administration (FDA) for the treatment of dogs with non-metastatic, cutaneous mast cell tumors [61]. Due to its efficacy, it is also being evaluated for human cancer treatment [62]. 18 was found to be highly selective for PKC isozymes, with particularly potent activation of PKCβ, weak activation of PKCα and PKCγ, and without activity against other isozymes. In vivo studies in mice demonstrated that the efficacy of 18 was inhibited by the PKC inhibitor bisindolylmaleimide 1 (BIM-1), suggesting that the anti-cancer activity of 18 is PKC-dependent [63].
18 has a β-oriented 5-hydroxy group and an α-oriented 6,7-epoxy group in the B-ring. Initially, it was believed that the α-oriented 6,7-epoxy group was an important motif in the anti-cancer activity of 18 through selective activation of PKC [63]. However, recently the study of 18 revealed that both affinity and selectivity for PKCβ and PKCθ were maintained when an epoxy group is changed to a double bond, whereas when changed to a 6-ene structure, such as PMA (1), showed a significant increase in affinity for PKCβ and PKCθ, but the selectivity disappeared [47]. Although previous binding experiments between phorbol esters and the C1 domain of PKCδ have indicated that the oxygen functional groups at C-3, C-4, and C-20 are involved in binding to PKC, a series of validations using 16 and its derivatives revealed that the hydroxy group at C-5, as well as the α-oriented 6,7-epoxy group, are an important motif for PKC isozyme selectivity (Fig. 16) [64]. Furthermore, the different acyl groups attached at C-12 and C-13 affect the affinity for PKC and cytotoxicity against cancer cell lines, suggesting that the kind of ester substituent at the C-12 and C-13 is also important for binding to PKC and their anti-cancer activity [47, 65].
Since mezerein (20) was identified as a potent antileukemic compound from Daphne mezereum in the 1970s, the anti-cancer activity of daphnane diterpenoids attracted much attention [66]. Several daphnanaes, such as yuhuancin (21), genkwadaphnin (22), and gnidimacrin (23), have been reported to demonstrate favorable anti-cancer activity against various types of cancer cells in both in vitro and in vivo studies [67,68,69,70,71,72,73,74,75,76,77,78,79,80]. However, unlike tiglianes, no daphnanes has reached clinical application yet.
The antiproliferative activity of tigliane and daphnane diterpenoids on various cancer cell lines has been extensively studied in the literature [81,82,83,84]. However, evaluating their anti-cancer activity solely based on in vitro growth inhibition results requires caution. This is because the expression profiles of PKC isozymes in different cancer cell lines can vary significantly, and the IC50 values for the same compound can range from nM to µM depending on the evaluation protocol, particularly the duration of drug exposure [65, 85,86,87]. Additionally, studies have compared tigilanol tiglate (18) and PMA (1), revealing that the effects of this class of compounds on tumor cells in vivo may not be linked to their effects in vitro [63]. Several instances of variations in sensitivity to anti-cancer drugs in vitro and in vivo or in three-dimensional cell models have been documented, indicating that the in vivo efficacy of tigliane and daphnane diterpenoids might be mediated by different mechanisms than those observed in vitro. Thus, further careful investigation is necessary [88].
Anti-HIV activity
Tigliane and daphnane diterpenoids exhibit another crucial biological activity through PKC activation, which is their anti-HIV activity. These diterpenoids display dual activity against HIV-1, inhibiting its replication, while also activating the latent HIV-1 in CD4+ T cells. This indicates their potential as latency-reversing agents (LRAs) which are of great interest for curing HIV-infection based on a “shock and kill” strategy [89]. The discovery of prostratin (16) has increased attention toward such activities.
Prostratin (16) was firstly isolated from Pimelea prostrata in 1976 and later rediscovered in Homalanthus nutans (commonly known as the Malala tree, Euphorbiaceae). It is a non-tumor promoter phorbol ester that exhibits potent cytoprotective activity against HIV-1-infected human lymphocyte cells [90,91,92]. Further studies have demonstrated that 16 not only reactivates latent infections but also inhibits HIV entry into host T cells by downregulating the expression of the HIV-1 receptor (CD4) and co-receptors (CXCR4 and CCR5) on the cell surface [93,94,95]. Structure–activity relationship studies have shown that altering the C-13 moiety of 16 and 12-deoxyphorbol-13-phenylacetate (DPP, 17) affects latent HIV activation and affinity for PKC. The aromatic, relatively lipophilic unit is more favorable for anti-HIV activity [96,97,98]. Recent studies suggest that 12-benzoyloxyphorbol may be more effective than 12-deoxyphorbol in displaying anti-HIV activity [42]. However, current r studies on 12-benzoyloxyphorbols have been limited to in vitro HIV replication inhibition and HIV LTR-driven transcription activity, and further investigation into their latent HIV activation activity is needed [33, 42, 99,100,101].
In contrast to prostratin (16), the MDOs gnidimacrin (23) and wikstroelide E (24) exhibited about 1000 times greater potency in activating HIV-1 latent infection in cell lines like U1, ACH-2, and J-Lat [102, 103]. Mechanistic studies on 23 reveal its selective activation of PKCβ1 and PKCβ2, while not affecting PKCα, which is involved in tumor promoter activity, and PKCθ, which regulates T cell differentiation induction [104]. Furthermore, 23 did not induce T cell activation through CD3 and CD28, which leads to T cell depletion in HIV infection. It also does not trigger the production of inflammatory cytokines. Ex vivo experiments conducted on peripheral blood mononuclear cells (PBMCs) from HIV patients with undetectable levels of HIV-1 after years of antiretroviral therapy (ART) reveal that even at concentrations as low as pM, 23 can significantly decrease HIV-1 DNA and the frequency of HIV-1-infected cells.
The studies on 16 and 23, which are tigliane and daphnane diterpenoids, to activate latent HIV are associated with their capacity to inhibit HIV replication. Studies on the structure–activity relationship of daphnanes for anti-HIV activity have revealed that the A-ring structure is crucial, with the five-membered A-ring structure being beneficial for anti-HIV activity, while compounds with a bicyclo A-ring structure decrease activity (Fig. 16) [35,36,37]. Among MDOs with a five-membered A-ring structure, compounds with a benzoyl group attached to the C-3 and hydroxy groups attached to the C-5, C-20, and C-2′ are important for the anti-HIV activity [101, 105]. In addition, orthoester daphnanes have potent HIV replication inhibitory activity, with an EC50 value of single digit nanomolar, which is more potent than the polyhydroxy daphnanes but less active than the MDOs [34, 36, 106]. These suggest that the macrocyclic ring part and orthoester moiety are essential motifs for enhancing the anti-HIV activity in daphnanes (Fig. 17).
Conclusions
This review focuses on tigliane and daphnane diterpenoids isolated from plants of the Thymelaeaceae family, which have promising potential as anti-cancer and anti-HIV drug candidates. However, the complex chemical structures make their total synthesis a challenging task, and securing sufficient quantities of compounds remains a major obstacle. While some of these compounds have been/are in clinical trials, drug discovery research has not progressed well. Therefore, the development of efficient and practical total/semi-synthetic methods and further exploration of plant resources are eagerly awaited. Recently, target isolation using LC-tandem mass spectrometry and the molecular network has improved the efficiency of these diterpenoids [22, 42, 107,108,109]. It is hoped that further dereplication using LC–MS and molecular network strategies will lead to the discovery of new compounds with even more attractive chemical structures and biological activities. The establishment of a stable supply of these attractive diterpenoids is expected to lead to the development of novel pharmaceuticals.
References
Plants of the world Online. https://powo.science.kew.org/. Accessed 31 March 2023
The World Flora Online. http://www.worldfloraonline.org/taxon/wfo-7000000613#G. Accessed 31 March 2023
Li W, Chen HQ, Wang H, Mei WL, Dai HF (2021) Natural products in agarwood and Aquilaria plants: chemistry, biological activities and biosynthesis. Nat Prod Rep 38:528–565. https://doi.org/10.1039/d0np00042f
Hubbe MA, Bowden CW (2009) Handmade paper: a review of its history, craft, and science. Bioresources 4:1736–1792. https://doi.org/10.15376/BIORES.4.4.1736-1792
Shirai K (1985) Tyuyakudaiziten, vol 15. Shanghai Scientific & Technical Publishers, Shougakukan Inc., Tokyo
Diamond L, O’Brien TG, Baird WM (1980) Tumor promoters and the mechanism of tumor promotion. Adv Cancer Res 32:1–74. https://doi.org/10.1016/s0065-230x(08)60360-7
Hergenhahn M, Adolf W, Hecker E (1975) Resiniferatoxin and other esters of novel polyfunctional diterpenes from Euphorbia resinifera and unispina. Tetrahedron lett 19:1595–1598
Elokely K, Velisetty P, Delemotte L, Palovcak E, Klein ML, Rohacs T, Carnevale V (2016) Understanding TRPV1 activation by ligands: Insights from the binding modes of capsaicin and resiniferatoxin. Proc Natl Acad Sci USA 113:E137–E145. https://doi.org/10.1073/pnas.1517288113
Szallasi A, Blumberg PM (1990) Resiniferatoxin and its analogs provide novel insights into the pharmacology of the vanilloid (capsaicin) receptor. Life Sci 147:1399–1408. https://doi.org/10.1016/0024-3205(90)90518-v
ClinicalTrials.gov https://clinicaltrials.gov/ct2/home. Accessed 31 March 2023
Liao SG, Chen HD, Yue JM (2009) Plant orthoesters. Chem Rev 109:1092–1140. https://doi.org/10.1021/cr0782832
Wang HB, Wang XY, Liu LP, Qin GW, Kang TG (2015) Tigliane diterpenoids from the Euphorbiaceae and Thymelaeaceae families. Chem Rev 115:2975–3011. https://doi.org/10.1021/cr200397n
Evans FJ, Taylor SE (1983) Pro-inflammatory, tumour-promoting and anti-tumour Diterpenes of the plant families Euphorbiaceae and Thymelaeaceae. In: Fortschritte der Chemie organischer Naturstoffe/Progress in the chemistry of organic natural products, vol 44. Springer, Vienna. https://doi.org/10.1007/978-3-7091-8714-2_1
Moesta P, West CA (1985) Casbene synthetase: regulation of phytoalexin biosynthesis in Ricinus communis L. seedlings. Purification of casbene synthetase and regulation of its biosynthesis during elicitation. Arch Biochem Biophys 238:325–333. https://doi.org/10.1016/0003-9861(85)90171-7
Zayed S, Adolf W, Hafez A, Hecker E (1977) New highly irritant 1-alkyldaphnane derivatives from several species of Thymelaeaceae. Tetrahedron Lett 39:3481–3482. https://doi.org/10.1016/S0040-4039(01)83271-8
Adolf W, Seip EH, Hecker E, Dossaji SF (1988) Irritant principles of the mezereon family (Thymelaeaceae), V. New skin irritants and tumor promoters of the daphnane and 1α-alkyldaphnane type from Synaptolepis kirkii and Synaptolepis retusa. J Nat Prod 51:662–674. https://doi.org/10.1021/np50058a003
He W, Cik M, Van Puyvelde L, Van Dun J, Appendino G, Lesage A, Van der Lindin I, Leysen JE, Wouters W, Mathenge SG, Mudida FP, De Kimpe N (2002) Neurotrophic and antileukemic daphnane diterpenoids from Synaptolepis kirkii. Bioorg Med Chem 10:3245–3255. https://doi.org/10.1016/s0968-0896(02)00163-3
Asada Y, Otsuki K, Morooka M, Huang L, Chen CH, Koike K, Li W (2022) Anti-HIV macrocyclic daphnane orthoesters with an unusual macrocyclic ring from Edgeworthia chrysantha. J Nat Prod 85:2399–2405. https://doi.org/10.1021/acs.jnatprod.2c00618
Hayes PY, Chow S, Somerville MJ, Fletcher MT, De Voss JJ (2010) Daphnane- and tigliane-type diterpenoid esters and orthoesters from Pimelea elongata. J Nat Prod 73:1907–1913. https://doi.org/10.1021/np1005746
Guo J, Tian J, Yao G, Zhu H, Xue Y, Luo Z, Zhang J, Zhang Y, Zhang Y (2015) Three new 1α-alkyldaphnane-type diterpenoids from the flower buds of Wikstroemia chamaedaphne. Fitoterapia 106:242–246. https://doi.org/10.1016/j.fitote.2015.09.017
Zhang M, Otsuki K, Kato S, Ikuma Y, Kikuchi T, Li N, Koike K, Li W (2021) A feruloylated acylglycerol isolated from Wikstroemia pilosa and its distribution in ten plants of Wikstroemia species. J Nat Med 76:680–685. https://doi.org/10.1007/s11418-022-01621-6
Otsuki K, Zhang M, Kikuchi T, Tsuji M, Tejima M, Bai ZS, Zhou D, Huang L, Chen CH, Lee KH, Li N, Koike K, Li W (2021) Identification of anti-HIV macrocyclic daphnane orthoesters from Wikstroemia ligustrina by LC-MS analysis and phytochemical investigation. J Nat Med 75:1058–1066. https://doi.org/10.1007/s11418-021-01551-9
Schmidt R, Hecker E (1975) Autoxidation of phorbol esters under normal storage conditions. Cancer Res 35:1375–1377
Powell RG, Weisleder D, Smith CR Jr (1985) Daphnane diterpenes from Diarthron vesiculosum: vesiculosin and isovesiculosin. J Nat Prod 48:102–107. https://doi.org/10.1021/np50037a018
Nyborg J, La Cour T (1975) X-ray diffraction study of molecular structure and conformation of mezerein. Nature 257:824–825. https://doi.org/10.1038/257824a0
McCormick IRN, Nixon PE, Waters TN (1976) On the structure of prostratin: an X-ray study. Tetrahedron Lett 20:1735–1736. https://doi.org/10.1016/S0040-4039(00)92939-3
Kupchan SM, Shizuri Y, Murae T, Swenny JG, Haynes HR, Shen MS, Barrick JC, Bryan AF, vander Helm D, Wu KK (1976) Letter: Gnidimacrin and gnidimacrin 20-palmitate, novel macrocyclic antileukemic diterpenoid esters from Gnidia subcordata. J Am Chem Soc 98:5719–5720. https://doi.org/10.1021/ja00434a063
Li LZ, Song SJ, Gao PY, Li FF, Wang LH, Liu QB, Huang XX, Lia DQ, Sun Y (2015) Neogenkwanines A-H: daphnane-type diterpenes containing 4,7 or 4,6-ether groups from the flower bud of Daphne genkwa. RSC Adv 5:4143–4152. https://doi.org/10.1039/c4ra13167c
Du Q, Zhao Y, Liu H, Tang C, Zhang M, Ke C, Ye Y (2017) Isolation and structure characterization of cytotoxic phorbol esters from the seeds of Croton tiglium. Planta Med 83:1361–1367. https://doi.org/10.1055/s-0043-110227
Pieters LAC, Vlietinck AJ (1987) 13C NMR spectroscopy of phorbol esters. Magn Reson Chem 25:368–370. https://doi.org/10.1002/mrc.1260250420
Klausen TK, Pagani A, Minassi A, Ech-Chahad A, Prenen J, Owsianik G, Hoffmann EK, Pedersen SF, Appendino G, Nilius B (2009) Modulation of the transient receptor potential vanilloid channel TRPV4 by 4α-phorbol esters: a structure-activity study. J Med Chem 52:2933–2939. https://doi.org/10.1021/jm9001007
Snatzke G, Hruban L, Snatzke F, Schmidt R, Hecker E (1977) Chemistry of phorbol. XIX. On circular dichroism. LXX. Chiroptical properties of phorbol-12,13,20-triacetate and some other phorbol derivatives. Isr J Chem 15:46–56. https://doi.org/10.1002/ijch.197600010
Otsuki K, Zhang M, Yamamoto A, Tsuji M, Tejima M, Bai ZS, Zhou D, Huang L, Chen CH, Lee KH, Li N, Li W, Koike K (2020) Anti-HIV tigliane diterpenoids from Wikstroemia scytophylla. J Nat Prod 83:3584–3590. https://doi.org/10.1021/acs.jnatprod.0c00700
Otsuki K, Li W, Miura K, Asada Y, Huang L, Chen CH, Lee KH, Koike K (2020) Isolation, structural elucidation, and anti-HIV activity of daphnane diterpenoids from Daphne odora. J Nat Prod 83:3270–3277. https://doi.org/10.1021/acs.jnatprod.0c00540
Tan L, Otsuki K, Zhang M, Kikuchi T, Okayasu M, Azumaya I, Zhou D, Li N, Huang L, Chen CH, Li W (2022) Daphnepedunins A-F, anti-HIV macrocyclic daphnane orthoester diterpenoids from Daphne pedunculata. J Nat Prod 85:2856–2864. https://doi.org/10.1021/acs.jnatprod.2c00894
Yan M, Lu Y, Chen CH, Zhao Y, Lee KH, Chen DF (2015) Stelleralides D-J and anti-HIV daphnane diterpenes from Stellera chamaejasme. J Nat Prod 78:2712–2718. https://doi.org/10.1021/acs.jnatprod.5b00660
Asada Y, Sukemori A, Watanabe T, Malla KJ, Yoshikawa T, Li W, Koike K, Chen CH, Akiyama T, Qian K, Nakagawa-Goto K, Morris-Natschke SL, Lee KH (2011) Stelleralides A-C, novel potent anti-HIV daphnane-type diterpenoids from Stellera chamaejasme L. Org Lett 13:2904–2907. https://doi.org/10.1021/ol200889s
Hayes PY, Chow S, Somerville MJ, De Voss JJ, Fletcher MT (2009) Pimelotides A and B, diterpenoid ketal-lactone orthoesters with an unprecedented skeleton from Pimelea elongata. J Nat Prod 72:2081–2083. https://doi.org/10.1021/np900573k
Wang HB, Liu LP, Wang XY (2013) 13C-NMR data of daphnane diterpenoids. Magn Reson Chem 51:580–592. https://doi.org/10.1002/mrc.3978
Trinel M, Jullian V, Le Lamer AC, Mhamdi I, Mejia K, Castillo D, Cabanillas BJ, Fabre N (2018) Profiling of Hura crepitans L. latex by ultra-high-performance liquid chromatography/atmospheric pressure chemical ionisation linear ion trap Orbitrap mass spectrometry. Phytochem Anal 29:627–638. https://doi.org/10.1002/pca.2776
Zhao HD, Lu Y, Yan M, Chen CH, Morris-Natschke SL, Lee KH, Chen DF (2020) Rapid recognition and targeted isolation of anti-HIV daphnane diterpenes from Daphne genkwa guided by UPLC-MSn. J Nat Prod 83:134–141. https://doi.org/10.1021/acs.jnatprod.9b00993
Zhang M, Otsuki K, Kikuchi T, Bai ZS, Zhou D, Huang L, Chen CH, Morris-Natschke SL, Lee KH, Li N, Koike K, Li W (2021) LC-MS identification, isolation, and structural elucidation of anti-HIV tigliane diterpenoids from Wikstroemia lamatsoensis. J Nat Prod 84:2366–2373. https://doi.org/10.1021/acs.jnatprod.1c00570
Liu Z, Ding Z, Chen K, Xu M, Yu T, Tong G, Zhang H, Li P (2021) Balancing skeleton and functional groups in total syntheses of complex natural products: a case study of tigliane, daphnane and ingenane diterpenoids. Nat Prod Rep 38:1589–1617. https://doi.org/10.1039/d0np00086h
Wender PA, Lee HY, Wilhelm RS, Williams PD (1989) Studies on tumor promoters. 7. The synthesis of a potentially general precursor of the tiglianes, daphnanes, and ingenanes. J Am Chem Soc 111:8954–8957. https://doi.org/10.1021/ja00206a049
Wender PA, Kogen H, Lee HY, Munger JD, Wilhelm RS, Williams PD (1989) Studies on tumor promoters. 8. The synthesis of phorbol. J Am Chem Soc 111:8957–8958. https://doi.org/10.1021/ja00206a050
Wender PA, Kee JM, Warrington JM (2008) Practical synthesis of prostratin, DPP, and their analogs, adjuvant leads against latent HIV. Science 320:649–652. https://doi.org/10.1126/science.1154690
Wender PA, Gentry ZO, Fanelli DJ, Luu-Nguyen QH, McAteer OD, Njoo E (2022) Practical synthesis of the therapeutic leads tigilanol tiglate and its analogues. Nat Chem 14:1421–1426. https://doi.org/10.1038/s41557-022-01048-2
Wender PA, Jesudason CD, Nakahira H, Tamura N, Tebbe AL, Ueno Y (1997) The First Synthesis of a Daphnane Diterpene: The enantiocontrolled total synthesis of (+)-resiniferatoxin. J Am Chem Soc 119:12976–12977. https://doi.org/10.1021/ja972279y
Vasilev VH, Spessert L, Yu K, Maimone TJ (2022) Total synthesis of resiniferatoxin. J Am Chem Soc 144:16332–16337. https://doi.org/10.1021/jacs.2c08200
Hikone Y, Kato T, Nagatomo M, Inoue M (2022) Total synthesis of resiniferatoxin enabled by photocatalytic decarboxylative radical cyclization. Org Lett 24:929–933. https://doi.org/10.1021/acs.orglett.1c04286
Wender PA, Buschmann N, Cardin NB, Jones LR, Kan C, Kee JM, Kowalski JA, Longcore KE (2011) Gateway synthesis of daphnane congeners and their protein kinase C affinities and cell-growth activities. Nat Chem 3:615–619. https://doi.org/10.1038/nchem.1074
Wender PA, D’Angelo N, Elitzin VI, Ernst M, Jackson-Ugueto EE, Kowalski JA, McKendry S, Rehfeuter M, Sun R, Voigtlaender D (2007) Function-oriented synthesis: studies aimed at the synthesis and mode of action of 1alpha-alkyldaphnane analogues. Org Lett 9:1829–1832. https://doi.org/10.1021/ol0705649
Nishizuka Y (1986) Studies and perspectives of protein kinase C. Science 233:305–312
Castagna M, Takai Y, Kaibuchi K, Sano K, Kikkawa U, Nishizuka Y (1982) Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J Biol Chem 257:7847–7851
Aitken A (1987) The activation of protein kinase C by daphnane, ingenane and tigliane diterpenoid esters. Bot J Linnean Soc 94:247–263. https://doi.org/10.1111/j.1095-8339.1987.tb01049.x
Isakov N (2018) Protein kinase C (PKC) isoforms in cancer, tumor promotion and tumor suppression. Semin Cancer Biol 48:36–52. https://doi.org/10.1016/j.semcancer.2017.04.012
Mochly-Rosen D, Das K, Grimes KV (2012) Protein kinase C, an elusive therapeutic target? Nat Rev Drug Discov 11:937–957. https://doi.org/10.1038/nrd3871
Antal CE, Hudson AM, Kang E, Zanca C, Wirth C, Stephenson NL, Trotter EW, Gallegos LL, Miller CJ, Furnari FB, Hunter T, Brognard J, Newton AC (2015) Cancer-associated protein kinase C mutations reveal kinase’s role as tumor suppressor. Cell 160:489–502. https://doi.org/10.1016/j.cell.2015.01.001
Newton AC, Brognard J (2017) Reversing the paradigm: protein Kinase C as a tumor suppressor. Trends Pharmacol Sci 38:438–447. https://doi.org/10.1016/j.tips.2017.02.002
Newton AC (2017) Protein kinase C as a tumor suppressor. Semin Cancer Biol 48:18–26. https://doi.org/10.1016/j.semcancer.2017.04.017
FDA approves first intratumoral injection to treat non-metastatic mast cell tumors in dogs. https://www.fda.gov/news-events/press-announcements/fda-approves-first-intratumoral-injection-treat-non-metastatic-mast-cell-tumors-dogs. Accessed 31 March 2023
Panizza BJ, de Souza P, Cooper A, Roohullah A, Karapetis CS, Lickliter JD (2019) Phase I dose-escalation study to determine the safety, tolerability, preliminary efficacy and pharmacokinetics of an intratumoral injection of tigilanol tiglate (EBC-46). EBioMedicine 50:433–441. https://doi.org/10.1016/j.ebiom.2019.11.037
Boyle GM, D’Souza MM, Pierce CJ, Adams RA, Cantor AS, Johns JP, Maslovskaya L, Gordon VA, Reddell PW, Parsons PG (2014) Intra-lesional injection of the novel PKC activator EBC-46 rapidly ablates tumors in mouse models. PLoS One 9:e108887. https://doi.org/10.1371/journal.pone.0108887
Zhang G, Kazanietz MG, Blumberg PM, Hurley JH (1995) Crystal structure of the cys2 activator-binding domain of protein kinase Cδ in complex with phorbol ester. Cell 81:917–924. https://doi.org/10.1016/0092-8674(95)90011-x
Cullen JK, Boyle GM, Yap PY, Elmlinger S, Simmons JL, Broit N, Johns J, Ferguson B, Maslovskaya LA, Savchenko AI, Mirzayans PM, Porzelle A, Bernhardt PV, Gordon VA, Reddell PW, Pagani A, Appendino G, Parsons PG, Williams CM (2021) Activation of PKC supports the anticancer activity of tigilanol tiglate and related epoxytiglianes. Sci Rep 11:207. https://doi.org/10.1038/s41598-020-80397-9
Kupchan SM, Baxter RL (1975) Mezerein: antileukemic principle isolated from Daphne mezereum L. Science 187:652–653. https://doi.org/10.1126/science.1114315
Tyler MI, Howden ME (1985) Antineoplastic and piscicidal 1-alkyldaphnane orthoesters from Pimelea species. J Nat Prod 48:440–445. https://doi.org/10.1021/np50039a012
Yoshida M, Feng W, Saijo N, Ikekawa T (1996) Antitumor activity of daphnane-type diterpene gnidimacrin isolated from Stellera chamaejasme L. Int J Cancer 66:268–273. https://doi.org/10.1002/(SICI)1097-0215(19960410)66:2%3c268::AID-IJC22%3e3.0.CO;2-7
Yoshida M, Yokokura H, Hidaka H, Ikekawa T, Saijo N (1998) Mechanism of antitumor action of PKC activator, gnidimacrin. Int J Cancer 77:243–250. https://doi.org/10.1002/(sici)1097-0215(19980717)77:2%3c243::aid-ijc13%3e3.0.co;2-c
Yoshida M, Feng W, Nishio K, Takahashi M, Heike Y, Saijo N, Wakasugi H, Ikekawa T (2001) Antitumor action of the PKC activator gnidimacrin through cdk2 inhibition. Int J Cancer 94:348–352. https://doi.org/10.1002/ijc.1476
Yoshida M, Heike Y, Ohno S, Ikekawa T, Wakasugi H (2003) Involvement of PKC βII in anti-proliferating action of a new antitumor compound gnidimacrin. Int J Cancer 105:601–606. https://doi.org/10.1002/ijc.11157. (PMID: 12740906)
Li ZJ, Li XM, Piao YJ, Choi DK, Kim SJ, Kim JW, Sohn KC, Kim CD, Lee JH (2014) Genkwadaphnin induces reactive oxygen species (ROS)-mediated apoptosis of squamous cell carcinoma (SCC) cells. Biochem Biophys Res Commun 450:1115–1119. https://doi.org/10.1016/j.bbrc.2014.06.118
Zhang R, Wang Y, Li J, Jin H, Song S, Huang C (2014) The Chinese herb isolate yuanhuacine (YHL-14) induces G2/M arrest in human cancer cells by up-regulating p21 protein expression through an p53 protein-independent cascade. J Biol Chem 289:6394–6403. https://doi.org/10.1074/jbc.M113.513960
Bailly C (2022) Yuanhuacin and related anti-inflammatory and anticancer daphnane diterpenes from Genkwa Flos—an overview. Biomolecules 12:192. https://doi.org/10.3390/biom12020192
Hong JY, Chung HJ, Lee HJ, Park HJ, Lee SK (2011) Growth inhibition of human lung cancer cells via down-regulation of epidermal growth factor receptor signaling by yuanhuadine, a daphnane diterpene from Daphne genkwa. J Nat Prod 74:2102–2108. https://doi.org/10.1021/np2003512
Kang JI, Hong JY, Lee HJ, Bae SY, Jung C, Park HJ, Lee SK (2015) Anti-tumor activity of yuanhuacine by regulating AMPK/mTOR signaling pathway and actin cytoskeleton organization in non-small cell lung cancer cells. PLoS One 10:e0144368. https://doi.org/10.1371/journal.pone.0144368
Villareal MO, Sato Y, Matsuyama K, Isoda H (2018) Daphnane diterpenes inhibit the metastatic potential of B16F10 murine melanoma cells in vitro and in vivo. BMC Cancer 18:856. https://doi.org/10.1186/s12885-018-4693-y
Wu J, Guo L, Qiu X, Ren Y, Li F, Cui W, Song S (2020) Genkwadaphnin inhibits growth and invasion in hepatocellular carcinoma by blocking DHCR24-mediated cholesterol biosynthesis and lipid rafts formation. Br J Cancer 123:1673–1685. https://doi.org/10.1038/s41416-020-01085-z
Fermaintt CS, Peramuna T, Cai S, Takahashi-Ruiz L, Essif JN, Grant CV, O’Keefe BR, Mooberry SL, Cichewicz RH, Risinger AL (2021) Yuanhuacine is a potent and selective inhibitor of the basal-like 2 subtype of triple negative breast cancer with immunogenic potential. Cancers (Basel) 13:2834. https://doi.org/10.3390/cancers13112834
Huang JL, Yan XL, Li W, Fan RZ, Li S, Chen J, Zhang Z, Sang J, Gan L, Tang GH, Chen H, Wang J, Yin S (2022) Discovery of highly potent daphnane diterpenoids uncovers importin-β1 as a druggable vulnerability in castration-resistant prostate cancer. J Am Chem Soc 144:17522–17532. https://doi.org/10.1021/jacs.2c06449
Jin YX, Shi LL, Zhang DP, Wei HY, Si Y, Ma GX, Zhang J (2019) A review on daphnane-type diterpenoids and their bioactive studies. Molecules 24:1842. https://doi.org/10.3390/molecules24091842
Moshiashvili G, Tabatadze N, Mshvildadze V (2020) The genus Daphne: a review of its traditional uses, phytochemistry and pharmacology. Fitoterapia 143:104540. https://doi.org/10.1016/j.fitote.2020.104540
Nie YW, Li Y, Luo L, Zhang CY, Fan W, Gu WY, Shi KR, Zhai XX, Zhu JY (2021) Phytochemistry and pharmacological activities of the diterpenoids from the genus Daphne. Molecules 26:6598. https://doi.org/10.3390/molecules26216598
Hou ZL, Yao GD, Song SJ (2021) Daphnane-type diterpenes from genus Daphne and their anti-tumor activity. Chin Herb Med 13:145–156. https://doi.org/10.1016/j.chmed.2020.09.006
Zhan ZJ, Fan CQ, Ding J, Yue JM (2005) Novel diterpenoids with potent inhibitory activity against endothelium cell HMEC and cytotoxic activities from a well-known TCM plant Daphne genkwa. Bioorg Med Chem 13:645–655. https://doi.org/10.1016/j.bmc.2004.10.054
Huang SZ, Zhang XJ, Li XY, Kong LM, Jiang HZ, Ma QY, Liu YQ, Hu JM, Zheng YT, Li Y, Zhou J, Zhao YX (2012) Daphnane-type diterpene esters with cytotoxic and anti-HIV-1 activities from Daphne acutiloba Rehd. Phytochemistry 75:99–107. https://doi.org/10.1016/j.phytochem.2011.11.013
Li F, Sun Q, Hong L, Li L, Wu Y, Xia M, Ikejima T, Peng Y, Song S (2013) Daphnane-type diterpenes with inhibitory activities against human cancer cell lines from Daphne genkwa. Bioorg Med Chem Lett 23:2500–2504. https://doi.org/10.1016/j.bmcl.2013.03.025
Edmondson R, Broglie JJ, Adcock AF, Yang L (2014) Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors. Assay Drug Dev Technol 12:207–218. https://doi.org/10.1089/adt.2014.573
Deeks SG (2012) HIV: Shock and kill. Nature 487:439–440. https://doi.org/10.1038/487439a
Cashmore AR, Seelye RN, Cain BF, Mack HH, Schmidt R, Hecker E (1976) The structure of prostratin: a toxic tetracyclic diterpene ester from Pimelea prostrata. Tetrahedron Lett 17:1737–1738. https://doi.org/10.1016/S0040-4039(00)92940-X
Gustafson KR, Cardellina JH 2nd, McMahon JB, Gulakowski RJ, Ishitoya J, Szallasi Z, Lewin NE, Blumberg PM, Weislow OS, Beutler JA, Buckheit RW, Cragg GM, Cox PA, Bader JP, Boyd MR (1992) A nonpromoting phorbol from the samoan medicinal plant Homalanthus nutans inhibits cell killing by HIV-1. J Med Chem 35:1978–1986. https://doi.org/10.1021/jm00089a006
Gulakowski RJ, McMahon JB, Buckheit RW Jr, Gustafson KR, Boyd MR (1997) Antireplicative and anticytopathic activities of prostratin, a non-tumor-promoting phorbol ester, against human immunodeficiency virus (HIV). Antiviral Res 33:87–97. https://doi.org/10.1016/s0166-3542(96)01004-2
Kulkosky J, Culnan DM, Roman J, Dornadula G, Schnell M, Boyd MR, Pomerantz RJ (2001) Prostratin: activation of latent HIV-1 expression suggests a potential inductive adjuvant therapy for HAART. Blood 98:3006–3015. https://doi.org/10.1182/blood.v98.10.3006
Korin YD, Brooks DG, Brown S, Korotzer A, Zack JA (2002) Effects of prostratin on T-cell activation and human immunodeficiency virus latency. J Virol 76:8118–8123. https://doi.org/10.1128/jvi.76.16.8118-8123.2002
Biancotto A, Grivel JC, Gondois-Rey F, Bettendroffer L, Vigne R, Brown S, Margolis LB, Hirsch I (2004) Dual role of prostratin in inhibition of infection and reactivation of human immunodeficiency virus from latency in primary blood lymphocytes and lymphoid tissue. J Virol 78:10507–10515. https://doi.org/10.1128/JVI.78.19.10507-10515.2004
Bocklandt S, Blumberg PM, Hamer DH (2003) Activation of latent HIV-1 expression by the potent anti-tumor promoter 12-deoxyphorbol 13-phenylacetate. Antiviral Res 59:89–98. https://doi.org/10.1016/s0166-3542(03)00034-2
Beans EJ, Fournogerakis D, Gauntlett C, Heumann LV, Kramer R, Marsden MD, Murray D, Chun TW, Zack JA, Wender PA (2013) Highly potent, synthetically accessible prostratin analogs induce latent HIV expression in vitro and ex vivo. Proc Natl Acad Sci U S A 110:11698–11703. https://doi.org/10.1073/pnas.1302634110
Sloane JL, Benner NL, Keenan KN, Zang X, Soliman MSA, Wu X, Dimapasoc M, Chun TW, Marsden MD, Zack JA, Wender PA (2020) Prodrugs of PKC modulators show enhanced HIV latency reversal and an expanded therapeutic window. Proc Natl Acad Sci U S A 117:10688–10698. https://doi.org/10.1073/pnas.1919408117
Zhou D, Otsuki K, Zhang M, Chen G, Bai ZS, Yu H, Kikuchi T, Huang L, Chen CH, Li W, Li N (2022) Anti-HIV Tigliane-Type Diterpenoids from the Aerial Parts of Wikstroemia lichiangensis. J Nat Prod 85:1658–1664. https://doi.org/10.1021/acs.jnatprod.1c01195
Asada Y, Sukemori A, Watanabe T, Malla KJ, Yoshikawa T, Li W, Kuang X, Koike K, Chen CH, Akiyama T, Qian K, Nakagawa-Goto K, Morris-Natschke SL, Lu Y, Lee KH (2013) Isolation, structure determination, and anti-HIV evaluation of tigliane-type diterpenes and biflavonoid from Stellera chamaejasme. J Nat Prod 76:852–857. https://doi.org/10.1021/np300815t
El-Desoky AHH, Eguchi K, Kishimoto N, Asano T, Kato H, Hitora Y, Kotani S, Nakamura T, Tsuchiya S, Kawahara T, Watanabe M, Wada M, Nakajima M, Watanabe T, Misumi S, Tsukamoto S (2022) Isolation, synthesis, and structure–activity relationship study on daphnane and tigliane diterpenes as HIV latency-reversing agents. J Med Chem 65:3460–3472. https://doi.org/10.1021/acs.jmedchem.1c01973
Huang L, Ho P, Yu J, Zhu L, Lee KH, Chen CH (2011) Picomolar dichotomous activity of gnidimacrin against HIV-1. PLoS One 6:e26677. https://doi.org/10.1371/journal.pone.0026677
Li SF, Liang X, Wu XK, Gao X, Zhang LW (2021) Discovering the mechanisms of wikstroelide E as a potential HIV-latency-reversing agent by transcriptome profiling. J Nat Prod 84:1022–1033. https://doi.org/10.1021/acs.jnatprod.0c01039
Lai W, Huang L, Zhu L, Ferrari G, Chan C, Li W, Lee KH, Chen CH (2015) Gnidimacrin, a potent anti-HIV diterpene, can eliminate latent HIV-1 ex vivo by activation of protein kinase Cβ. J Med Chem 58:8638–8646. https://doi.org/10.1021/acs.jmedchem.5b01233
Liu Q, Cheng YY, Li W, Huang L, Asada Y, Hsieh MT, Morris-Natschke SL, Chen CH, Koike K, Lee KH (2019) Synthesis and structure-activity relationship correlations of gnidimacrin derivatives as potent HIV-1 inhibitors and HIV latency reversing agents. J Med Chem 62:6958–6971. https://doi.org/10.1021/acs.jmedchem.9b00339
Otsuki K, Li W, Asada Y, Chen CH, Lee KH, Koike K (2020) Daphneodorins A-C, anti-HIV gnidimacrin related macrocyclic daphnane orthoesters from Daphne odora. Org Let 22:11–15. https://doi.org/10.1021/acs.orglett.9b03539
Guo R, Li Q, Mi SH, Jia SH, Yao GD, Lin B, Huang XX, Liu YY, Song SJ (2022) Target isolation of cytotoxic diterpenoid esters and orthoesters from Daphne tangutica maxim based on molecular networking. Phytochemistry 203:113358. https://doi.org/10.1016/j.phytochem.2022.113358
Zhou WY, Hou JY, Li Q, Wang YJ, Wang JY, Jiang MH, Yao GD, Huang XX, Song SJ (2022) Targeted isolation of diterpenoids and sesquiterpenoids from Daphne gemmata E. Pritz. ex Diels using molecular networking together with network annotation propagation and MS2LDA. Phytochemistr 204:113468. https://doi.org/10.1016/j.phytochem.2022.113468
Mi SH, Duan ZK, Wang YJ, Dong SH, Zhao P, Yao GD, Liu QB, Lin B, Song SJ, Huang XX (2023) Isolation of cytotoxic daphnane-type and tigliane-type diterpenoids from Daphne genkwa using MetGem software. New J Chem 47:1517–1524. https://doi.org/10.1039/D2NJ05276H
Acknowledgements
This work was supported by the Japan Society for the Promotion of Science KAKENHI 21K06619 (W. Li).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no competing financial interests to declare.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Otsuki, K., Li, W. Tigliane and daphnane diterpenoids from Thymelaeaceae family: chemistry, biological activity, and potential in drug discovery. J Nat Med 77, 625–643 (2023). https://doi.org/10.1007/s11418-023-01713-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11418-023-01713-x